Dates: 7 and 8 May2025
Location: The Inn at Longwood Medical, Boston, Massachusetts, USA
After the successful journey of a series of 37 Pharmacovigilance conferences,
Virtue Insight is proud to announce its 38th Pharmacovigilance 2025. We have
been delivering the conference through close collaboration with the industry
leaders for more than a decade. For the 2025 edition, the agenda includes a host
of new and exciting features.
This Year Focus Areas
Market Trends – Critique & Ways Forward
Challenges / Opportunities
Patient Safety / Patient Centricity
Impact of Technology – AI, ML, DA
RMP / REMS
Quality, Safety & Signal Detection
Automation in PV
Regulatory
Audits & Inspection
RWE / RWD
Outsourcing
Topics for Discussion and Presentation
Our congress offers a diverse range of topics, each presented as a potential focus for your company or conference:
• Antibody-Drug Conjugates (ADCs)
• Host Cell Protein (HCP) Risk Management
• Ancillary Materials for Cell Therapy
• New Vaccine Approaches
• Emerging Biotherapeutics, including Virus-Like Particles (VLPs) and extracellular vesicles
• Alternative Expression Systems for Bioproduction
• Viral Elimination Strategies
• Continuous vs. Classic Production Processes
• Regulatory Aspects of Innovative Molecules
• Transient Transfection and GMP Production
• Digitization of CMC Activities
Speaking Sessions:
Wednesday, May 7 2025
11:10 – 11:40
Having the right local setup to comply with country-specific pharmacovigilance obligations
José Miguel Rivas, PharmaLex
